022 24172311
Venture Capital
Private Equity

DataBoard Demo
PitchBoard | 17 July 2013

Looking For Acquisition Opportunities

by Charmi Gutka
Looking For Acquisition Opportunities
Share on Social Media Email Facebook Twitter Linkedin
An acquirer is looking to buy/acquire major stake in a profitable company in the healthcare, ITES and Telecom VAS segment.

Criterias include:

  • The company should be service oriented company with asset light business model with turnover of up to Rs. 40 Cr.
  • The company/business should have successfully crossed the proof of concept stage and should have steady revenue stream.
  • It should be profitable business with a robust business pipeline, primarily targeting mass market (not to any niche market segment).
  • The present management should be available to stay on at the choice of the buyer. However, the management control would invariably have to be with the buyer. They would look to acquire minimum 51% stake. While a majority stake/outright purchase is the preferred route, the client is open to considering JVs and buying minority stake as well (but with Affirmative rights).
  • Scalability of operations with the support of the buyer is an important criterion.
  • Preferably, it should be headquartered in North India/NCR
To respond to this deal : Go to PitchBoard

How Does PitchBoard Work?

1 Search/Post 2 Respond 3 Connect
DealCurry brings you a platform to post your deals or search from what´s available.
If you like what you see, and want to reach out to the counter party with more questions, use response sheet.
If all goes great and you´d like to connect, request an introduction. DealCurry will help you handshake.

Government Releases New Set Of FDI Reforms

Government Releases New Set Of FDI Reforms

To shore up more Foreign Investments, the government liberalized FDI limits in dozen sectors to boost the sagging economy. Stock markets reacted positively after the government relaxed FDI norms in several sectors.


Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

Clinical-stage specialty bio-pharmaceutical company Vyome Biosciences raises $14 million

The clinical-stage specialty bio-pharmaceutical company Vyome Biosciences Private Limited has raises $14 million in Series-C financing round. The financing round was led by a prominent New York based life sciences fund Perceptive Advisors. Apart from that the funding round saw participation of a Boston-based venture capital Romulus Capital along with existing investors.

Enter your Email address
to receive all the news